NCT00348387View on ClinicalTrials.gov

Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions
PoliomyelitisPolio
Interventions
BIOLOGICAL

Poliomyelitis Vaccine inactivated

0.5 mL, Intramuscular

BIOLOGICAL

Poliomyelitis Vaccine in Dragee Candy (Human Diploid Cell)

1g dragee, oral

Trial Locations (2)

541001

Guilin

542400

PingLe County

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00348387 - Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV | Biotech Hunter | Biotech Hunter